Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,044 papers from all fields of science
Search
Sign In
Create Free Account
Nelfinavir Mesylate
Known as:
Nelfinavir Monomethane Sulfonate
, Sulfonate, Nelfinavir Monomethane
, Mesylate, Nelfinavir
Expand
The mesylate salt form of nelfinavir, a synthetic antiviral agent that selectively binds to and inhibits human immunodeficiency virus (HIV) protease…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Narrower (2)
AG 1343
Viracept
Acquired Immunodeficiency Syndrome
Astemizole
Cisapride
Drug Allergy
Expand
Broader (4)
Antiviral Agents
Isoquinolines
Nelfinavir
Sulfonic Acids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Antiretroviral Agent Nelfinavir Mesylate
Cecilia G. Sanchez
,
Steven V. Molinski
,
+5 authors
J. Lasky
Arthritis & Rheumatology
2017
Corpus ID: 115788818
Transforming growth factor β1 (TGFβ1) is considered a key factor in fibrogenesis, and blocking TGFβ1 signaling pathways…
Expand
2009
2009
The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients
N. Crum‐Cianflone
,
K. H. Hullsiek
,
+7 authors
S. Wegner
Journal of Acquired Immune Deficiency Syndromes
2009
Corpus ID: 36223392
Background:Preclinical studies suggest that the antiretroviral agent, nelfinavir mesylate (NFV), may have antineoplastic…
Expand
2004
2004
Risk of Birth Defects Associated With Nelfinavir Exposure During Pregnancy
D. Covington
,
S. Conner
,
P. Doi
,
J. Swinson
,
E. Daniels
Obstetrics and Gynecology
2004
Corpus ID: 25346424
OBJECTIVE: The objective of this study was to examine the human teratogenic risk of the protease inhibitor, nelfinavir mesylate…
Expand
2003
2003
A process in need is a process indeed: scalable enantioselective synthesis of chiral compounds for the pharmaceutical industry.
M. Ikunaka
Chemistry
2003
Corpus ID: 39651218
This report deals with enantioselective synthesis of viracept 1 (nelfinavir mesylate, AG 1343), a potent HIV protease inhibitor…
Expand
Review
2000
Review
2000
Nelfinavir mesylate
P. Tebas
,
W. Powderly
Expert Opinion on Pharmacotherapy
2000
Corpus ID: 24126230
Nelfinavir is an inhibitor of the HIV-1 and HIV-2 protease, with good in vivo activity in HIV-infected patients. Nelfinavir is…
Expand
2000
2000
Long-term stability of nelfinavir mesylate in human plasma.
M. Turner
,
E. Acosta
Clinical Chemistry
2000
Corpus ID: 35323377
Nelfinavir mesylate (NFV) is an HIV protease inhibitor approved for the treatment of HIV infection. Since its introduction, NFV…
Expand
2000
2000
Decrease in methodone levels with nelfinavir mesylate.
E. McCance-Katz
,
S. Farber
,
P. Selwyn
,
A. O’Connor
American Journal of Psychiatry
2000
Corpus ID: 34340853
1998
1998
Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors.
S. Roberts
,
R. Summers
European Journal of Pharmacology
1998
Corpus ID: 22851578
The beta-adrenoceptor subtypes involved in cyclic AMP accumulation in rat soleus muscle were studied using beta1- beta2- and…
Expand
Highly Cited
1997
Highly Cited
1997
High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma.
E. Wu
,
J. Wilkinson
,
+4 authors
B. Shetty
Journal of Chromatography B: Biomedical Sciences…
1997
Corpus ID: 35452305
Highly Cited
1997
Highly Cited
1997
Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in…
A. Patick
,
T J Boritzki
,
L A Bloom
Antimicrobial Agents and Chemotherapy
1997
Corpus ID: 7797854
Nelfinavir mesylate (formerly AG1343) is a potent and selective, nonpeptidic inhibitor of human immunodeficiency virus type 1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE